Skip to main content

Table 1 GO enrichment analysis

From: Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis

Term

ID

Description

Count

p-value

BP

GO:0007517

Muscle organ development

12

3.32E−07

BP

GO:0060537

Muscle tissue development

11

2.37E−06

BP

GO:0014706

Striated muscle tissue development

10

1.09E−05

BP

GO:1901342

Regulation of vasculature development

10

2.16E−05

BP

GO:0033002

Muscle cell proliferation

9

1.40E−06

BP

GO:0045765

Regulation of angiogenesis

9

6.10E−05

BP

GO:0048545

Response to steroid hormone

9

6.35E−05

BP

GO:0007015

Actin filament organization

9

8.51E−05

BP

GO:0009896

Positive regulation of catabolic process

9

1.30E−04

BP

GO:0003012

Muscle system process

9

2.63E−04

CC

GO:0005925

Focal adhesion

9

6.18E−05

CC

GO:0005924

Cell-substrate adherens junction

9

6.54E−05

CC

GO:0030055

Cell-substrate junction

9

7.05E−05

CC

GO:0031252

Cell leading edge

7

0.001776937

CC

GO:0044449

Contractile fiber part

6

3.88E−04

CC

GO:0043292

Contractile fiber

6

5.25E−04

CC

GO:0062023

Collagen-containing extracellular matrix

6

0.008196759

CC

GO:0032154

Cleavage furrow

5

3.88E−06

CC

GO:0032155

Cell division site part

5

7.63E−06

CC

GO:0001725

Stress fiber

5

1.03E−05

MF

GO:0003779

Actin binding

15

1.87E−09

MF

GO:0051015

Actin filament binding

10

3.70E−08

MF

GO:0001228

DNA-binding transcription activator activity, RNA polymerase ii-specific

8

0.00122079

MF

GO:0005539

Glycosaminoglycan binding

6

8.21E−04

MF

GO:1901681

Sulfur compound binding

6

0.001290131

MF

GO:0048018

Receptor ligand activity

6

0.028441857

MF

GO:0008201

Heparin binding

5

0.00132645

MF

GO:0001158

Enhancer sequence-specific DNA binding

4

0.002587729

MF

GO:0035326

Enhancer binding

4

0.003859145

MF

GO:0005201

Extracellular matrix structural constituent

4

0.007879546